Literature DB >> 2105195

Intracerebral crises during treatment of diabetic ketoacidosis.

A L Rosenbloom1.   

Abstract

Sixty-nine instances of intracerebral complications of diabetic ketoacidosis (DKA), including 29 unpublished occurrences, were analyzed to determine predictive factors, the frequency of other disorders resembling cerebral edema, the effectiveness of intervention to reduce intracranial pressure, and whether any etiologic considerations appeared valid. The review failed to implicate rate of hydration, tonicity of administered fluids, rate of correction of glycemia, or use of bicarbonate. Infants and young children (less than 5 yr of age) were disproportionately represented (33%), as were new-onset patients (62%). Approximately 20% of patients were found to have localized basilar edema, hemorrhage, thromboses, or infection by computed tomography scan or on postmortem examination. The histories of 50% of the patients suggested a period of dramatic neurological change preceding respiratory arrest (RA) during which intervention might be effective. Twenty-three patients were treated for increased intracranial pressure before RA; 13 patients survived in an independent functional state, and 3 survived in a severely disabled or vegetative state. Only 3 of the remaining 46 patients survived normally: 2 were untreated and never developed RA, and 1 was given mannitol at the onset of apnea. This review supports close neurological monitoring and intervention to reduce intracranial pressure when there are definite signs of neurological compromise. However, treatment appears to be successful in only 50% of patients who give sufficient warning for such intervention, and they comprised half of the study population. Therefore, prevention of DKA remains the most important goal to avoid intracerebral complications.

Entities:  

Mesh:

Year:  1990        PMID: 2105195     DOI: 10.2337/diacare.13.1.22

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  44 in total

Review 1.  Fluid management in diabetic ketoacidosis.

Authors:  C D Inward; T L Chambers
Journal:  Arch Dis Child       Date:  2002-06       Impact factor: 3.791

Review 2.  Diabetic ketoacidosis.

Authors:  Kristina Casteels; Chantal Mathieu
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

Review 3.  Cerebral oedema in childhood diabetic ketoacidosis: is treatment a factor?

Authors:  T B Brown
Journal:  Emerg Med J       Date:  2004-03       Impact factor: 2.740

Review 4.  Management of diabetic ketoacidosis.

Authors:  Neil H White
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 6.514

Review 5.  Hyperglycemic comas in children: new insights into pathophysiology and management.

Authors:  Arlan L Rosenbloom
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

Review 6.  Cell volume regulation: a review of cerebral adaptive mechanisms and implications for clinical treatment of osmolal disturbances. I.

Authors:  H Trachtman
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

Review 7.  [Diabetic coma. Management of diabetic ketoacidosis and nonketotic hyperosmolar coma].

Authors:  J Hensen
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

Review 8.  Importance of timing of risk factors for cerebral oedema during therapy for diabetic ketoacidosis.

Authors:  A P C P Carlotti; D Bohn; M L Halperin
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

9.  Pediatric diabetic ketoacidosis, fluid therapy, and cerebral injury: the design of a factorial randomized controlled trial.

Authors:  Nicole S Glaser; Simona Ghetti; T Charles Casper; J Michael Dean; Nathan Kuppermann
Journal:  Pediatr Diabetes       Date:  2013-03-13       Impact factor: 4.866

Review 10.  Hyperglycemic crises in adult patients with diabetes.

Authors:  Abbas E Kitabchi; Guillermo E Umpierrez; John M Miles; Joseph N Fisher
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.